Citigroup
OTLK icon

Citigroup’s Outlook Therapeutics OTLK Stock Holding History

Citigroup’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22K Buy
+765
New +$474 ﹤0.01% 5397
2026
Q1 		– Sell
-1,554
Closed -$2.46K – 6271
2025
Q4 		$2.46K Sell
1,554
-14,424
-90% -$23K ﹤0.01% 5421
2025
Q3 		$16.9K Sell
15,978
-1,221
-7% -$2.11K ﹤0.01% 4873
2025
Q2 		$27.5K Sell
17,199
-561
-3% -$894 ﹤0.01% 5001
2025
Q1 		$21.7K Buy
17,760
+2,731
+18% +$4.79K ﹤0.01% 5076
2024
Q4 		$28.4K Buy
15,029
+2,693
+22% +$11.1K ﹤0.01% 5216
2024
Q3 		$65.9K Buy
12,336
+10,003
+429% +$73.2K ﹤0.01% 4931
2024
Q2 		$17.2K Buy
2,333
+778
+50% +$6.25K ﹤0.01% 5040
2024
Q1 		$18.6K Buy
1,555
+341
+28% +$2.76K ﹤0.01% 5052
2023
Q4 		$9.56K Buy
1,214
+1,200
+8,571% +$10.1K ﹤0.01% 5203
2023
Q3 		$64 Sell
14
-2,296
-99% -$50.8K ﹤0.01% 5501
2023
Q2 		$80.4K Buy
+2,310
New +$63K ﹤0.01% 4351
2023
Q1 		– Sell
-40
Closed -$862 – 5753
2022
Q4 		$862 Sell
40
-50
-56% -$1.09K ﹤0.01% 5425
2022
Q3 		$2K Sell
90
-298
-77% -$6.93K ﹤0.01% 5515
2022
Q2 		$8K Buy
388
+183
+89% +$5.26K ﹤0.01% 5456
2022
Q1 		$7K Sell
205
-942
-82% -$29.4K ﹤0.01% 5696
2021
Q4 		$31K Buy
1,147
+575
+101% +$20.5K ﹤0.01% 5255
2021
Q3 		$25K Buy
572
+364
+175% +$17.6K ﹤0.01% 5132
2021
Q2 		$10K Buy
+208
New +$9.65K ﹤0.01% 5665

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Citigroup's OTLK Position: Q2 2026 in Review

Citigroup opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 765 shares worth $1.22K. The stake represents ﹤0.01% of the portfolio and ranks #5397 among its holdings. This is a return to the name: Citigroup previously reported a position in OTLK as recently as Q4 2025.

Citigroup first reported a position in OTLK in Q2 2021 and has held it in 19 quarters since. The position peaked at $80.4K in Q2 2023. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Citigroup held 765 shares of Outlook Therapeutics worth $1.22K as of Q2 2026.
  • Outlook Therapeutics was a new Citigroup position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5397 holding.
  • Citigroup first reported a position in Outlook Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • Citigroup's Outlook Therapeutics position peaked at $80.4K in Q2 2023.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.